Makoto Sonobe
Papers
1
Total Citations
6
H-Index
1
About
Dr. Makoto Sonobe is a leading thoracic surgeon whose research focuses on the intersection of immunotherapy and surgical oncology, particularly for advanced non-small cell lung cancer (NSCLC). His major contribution lies in pioneering the concept of salvage surgery following immune checkpoint inhibitor (ICI) therapy for patients with initially unresectable disease. By demonstrating that surgical resection can be safely and effectively performed after ICIs have reduced tumor burden, Dr. Sonobe has helped redefine treatment paradigms for advanced NSCLC, offering a potentially curative option where none previously existed. His seminal 2024 work on this topic has already garnered 6 citations, reflecting its immediate impact on clinical practice. Dr. Sonobe’s research bridges the gap between medical and surgical oncology, providing critical data on patient selection, surgical timing, and perioperative outcomes. His work is essential reading for clinicians and researchers exploring multimodal approaches to lung cancer, and it underscores a transformative shift toward integrating immunotherapy with aggressive local control strategies to improve long-term survival.
Research Focus
Key Achievements
Top Papers
- 1